NCCS Starburst 250px

What Caught Our Eye: Idaho Allows Insurers to Ignore ACA Rules; Op-ed: Right to Try a ‘Disaster in the Making’; Financial Toxicity; and More

/in , , , , , ,
What Caught Our Eye (WCOE), February 2, 2018
What Caught Our Eye is our week-in-review blog series, where we recap the cancer policy articles, studies, and stories that caught our attention.

Affordable Care Act

“Obamacare will survive as Republicans give up on repeal”

https://twitter.com/dylanlscott/status/959121990710956033

By Dylan Scott, Vox.com — The Affordable Care Act is going to survive. The 2010 health care law has slowly but surely moved out of the line of fire. President Trump barely mentioned it in his State of the Union address Tuesday night. At their annual retreat this week in West Virginia, top Republicans signaled that the repeal dream is likely over.
Read More »

“Idaho ‘Pushing Envelope’ With Health Insurance Plan. Can It Do That?”

By Julie Appleby, Kaiser Health News — For the past year, the Trump administration and Republicans in Congress have led a charge to roll back the Affordable Care Act, signaling an openness to state changes.

Now, Idaho has jumped in, saying it will allow insurers to ignore some ACA rules on plans not sold on the marketplace, aiming to make these state-based plans less costly. Several of the changes are viewed by the law’s supporters as hits to its core consumer protections.
Read More »

Cancer Policy

“Opinion: I’m the ideal person to support right to try. But I can’t — it’s a disaster in the making”

By Michael Becker, Stat News — We already have a right to try, one that offers greater protection for the already vulnerable individuals who will use it than the new law the president promoted in his State of the Union address. The federal Right to Try Act isn’t a boon for patient rights. In fact, it could dismantle the very safety system that currently protects us — and that would be a disaster.
Read More »

“Trump Pledges To Lower Drug Costs — Can We Do It?”

OnPoint from WBUR — President Trump says in his State of the Union that going after the high cost of prescription drugs is a top priority. Politicians have promised for years to bring them down. We’ll examine his medical checklist, and the prospects for fixing an intractable problem.
Read More »

“Editorial: Price of Cancer Care and Its Tax on Quality of Life”

By George Tran and Yousuf Zafar — As drug costs continue to rise and as patients are increasingly expected to shoulder the burden, we must find novel ways to mitigate this issue to provide patients with the best possible disease outcome. Until we find long-term policy solutions that reduce drug prices and improve insurance design, the solution lies in the patient-physician relationship.
Read More »

Coping with Cancer

“Chemotherapy, a Trusty Weapon Against Cancer, Falls Out of Favor”

By Lucette Lagnado, Wall Street Journal — “The medical community has underestimated the side-effects and impact on a woman’s life. … We may be able to do less without compromising outcomes.” – Dr. Eric Winer, Dana-Farber Cancer Institute
Read More »

“Breast cancer treatments can raise risk of heart disease, American Heart Association warns”

By Laurie McGinley, Washington Post — “We want to make sure they get the best treatment for breast cancer — survival is the goal,” she said. “But it’s important for people to know that the heart needs to be taken care of before, during and after treatment.” – Dr. Lakshmi Mehta, Ohio State University
Read More »

More From “What Caught Our Eye” »

Follow us on Twitter: @CancerAdvocacy

What Caught Our Eye: ACA Stabilization Waiting Game; Living with Lung Cancer;...NCCS Starburst 250pxProtectOurCare 1024pxACA Update February 2, 2018 | GOP Unlikely to Try ACA Repeal Again as Trump...